Entering The Australian Medical Device Market: A Practical Guide

Entering the Australian medical device market requires more than submitting an application to the Therapeutic Goods Administration (TGA). Instead, the appropriate pathway depends on your device, its intended purpose, classification, regulatory evidence and the documentation available to demonstrate compliance.

For overseas manufacturers, understanding these requirements early can help establish a clearer and more efficient pathway to Australian market entry. Therefore, here is a practical overview of the key steps.

Confirm your product is a medical device

First, determine whether your product falls within the Australian definition of a medical device. In particular, the device’s intended purpose, indications and claims are important considerations and form the foundation for the regulatory pathway that follows.

TGA resource: Medical devices overview ↗

Determine the Australian device classification

Next, medical devices are classified according to the level of risk associated with their use. For example, general medical devices range from Class I through Class IIa and IIb to Class III, while separate classifications apply to certain other device types. Classification is important because it influences the regulatory evidence, conformity assessment and application requirements that apply.

However, manufacturers should not assume that a classification assigned in another jurisdiction will automatically be the same in Australia. Instead, the device should be assessed against the applicable Australian classification rules.

TGA resource: Classification of medical devices ↗

Assess compliance with the Essential Principles

In addition, medical devices supplied in Australia must comply with the applicable Essential Principles for safety and performance. Specifically, manufacturers are responsible for holding appropriate evidence demonstrating compliance with these requirements, which may include technical, scientific, engineering, risk-management and clinical evidence, depending on the device.

Additionally, the TGA also provides an Essential Principles checklist that can be used to document how the applicable requirements have been addressed.

TGA resource : Essential Principles — safety and performance requirements ↗ · Essential Principles checklist ↗

Confirm the appropriate regulatory evidence

Furthermore, manufacturers must have appropriate evidence demonstrating that the applicable conformity assessment procedures have been completed. Depending on the device and regulatory pathway, the TGA may accept certain evidence issued by comparable overseas regulators and assessment bodies. However, approval in another market does not automatically mean that a device can be supplied in Australia.

As a result, existing regulatory evidence should therefore be assessed against the Australian device classification and applicable regulatory pathway before proceeding with an application.

TGA resource: Australian regulatory evidence options for medical device applications ↗

Review your technical and clinical documentation

Likewise, the manufacturer must maintain documentation supporting the safety, performance and regulatory compliance of the device. For example, depending on the device, this may include:

Device descriptions and specifications
Risk-management documentation
Verification and validation evidence
Clinical evidence and clinical evaluation
Biological safety information
Labelling
Instructions for Use
Evidence demonstrating compliance with the Essential Principles

Consequently, identifying documentation gaps before an ARTG application is submitted can help reduce regulatory uncertainty later in the process.

Appoint an Australian Sponsor

Importantly, an overseas manufacturer requires an Australian Sponsor to supply medical devices in Australia. In particular, the Sponsor is an Australian-based legal entity that acts as the primary regulatory contact between the manufacturer and the TGA. Moreover, the Sponsor’s responsibilities extend beyond the initial application and include important ongoing regulatory and post-market obligations.

Therefore, choosing an Australian Sponsor should be considered an important part of the manufacturer’s Australian market-entry strategy.

TGA resource: Steps to supply for device sponsors ↗

Related RQSolutions Insight :A Guide to Appointing Your Australian Sponsor →

Apply for inclusion in the ARTG

Next, most medical devices must be included in the Australian Register of Therapeutic Goods (ARTG) before they can be legally supplied in Australia, unless an exemption or other applicable pathway applies. After that, the Australian Sponsor submits the application to the TGA.

In addition, the application requirements depend on factors including the device classification and regulatory evidence being relied upon. Similarly, some applications may also be subject to TGA assessment or audit requirements.

TGA resource: Medical device inclusion process ↗

Consider Australian labelling and UDI requirements

Besides that, manufacturers should also assess Australian requirements relating to:

Device labelling
Instructions for Use
Patient information materials, where applicable
Unique Device Identification (UDI) requirements

Ideally, these requirements should be considered as part of the market-entry process rather than after ARTG inclusion.

TGA resource: Unique Device Identification (UDI) Hub ↗

Maintain compliance after market entry

Finally, ongoing obligations continue after a medical device is supplied in Australia. For example, these can include requirements relating to:

Complaints and adverse events
Post-market surveillance
Safety and performance
Regulatory and device changes
TGA requests for information
Recalls and corrective actions
Maintaining appropriate regulatory evidence

Overall, Australian market access should therefore be considered an ongoing regulatory lifecycle rather than simply a registration exercise.

TGA resource: Medical device post-market responsibilities ↗

A structured approach to Australian market entry

In summary, the Australian regulatory pathway can vary significantly depending on the device. Before proceeding with an ARTG application, manufacturers should understand:

Device & intended purpose

Device & intended purposeAustralian classificationRegulatory pathwayRegulatory evidenceDocumentation readinessAustralian SponsorARTG applicationMarket entryOngoing compliance

Accordingly, establishing these requirements early can help manufacturers understand what evidence they already have, identify potential gaps and determine the most appropriate pathway before proceeding with an Australian application.

How RQSolutions can help

In addition, RQSolutions supports medical device manufacturers through the Australian market-entry process using established regulatory assessment and submission processes. Specifically, we can help manufacturers:

Determine the appropriate Australian medical device classification
Identify the applicable regulatory pathway
Assess existing conformity assessment and regulatory evidence
Review technical and clinical documentation for potential gaps
Assess compliance with the Australian Essential Principles
Provide Australian Sponsor support
Prepare and manage ARTG applications
Support Australian labelling and UDI requirements
Manage ongoing Australian regulatory and post-market obligations

Above all, our approach is designed to identify the correct regulatory pathway and potential gaps early, helping manufacturers understand what is required before proceeding with an Australian application.

Official TGA guidance

Finally, for further information, visit the TGA’s guidance for device manufacturers.

TGA — Steps to supply for device manufacturers ↗

This article provides general regulatory information and does not constitute legal or regulatory advice. Regulatory requirements should be assessed for the particular device, manufacturer and circumstances.

What The Latest TGA UDI Guidance Means For Medical Device Manufacturers

Australia’s Unique Device Identification (UDI) framework has moved from preparation to implementation. As a result, it brings new compliance responsibilities for medical device manufacturers and sponsors supplying devices in Australia.

From 1 July 2026, UDI requirements became mandatory for Class III and Class IIb medical devices, marking an important milestone in Australia’s transition to a nationally regulated UDI system. In addition, the TGA is progressively introducing the requirements for other device classes through to 2029.

TGA resource: About UDI in Australia ↗

Therefore, for manufacturers supplying, or planning to supply, medical devices in Australia, UDI should now be considered part of the broader regulatory compliance framework rather than simply a labelling exercise.

What is changing?

Specifically, Australia’s UDI system is intended to provide consistent identification of medical devices throughout their lifecycle. Moreover, it aims to improve device traceability, particularly during post-market activities such as safety investigations and recalls.

In particular, devices within scope must meet applicable requirements relating to UDI identifiers, labelling and packaging, and the submission of device information to the Australian Unique Device Identification Database (AusUDID).

Importantly, UDI requirements apply in addition to existing regulatory obligations for medical devices supplied in Australia. Likewise, they sit alongside labelling and ARTG duties rather than replacing them.

Manufacturers and sponsors can access the TGA's central collection of UDI guidance, implementation information and technical resources through the TGA Unique Device Identification (UDI) Hub ↗

The AusUDID is now an important part of compliance

Furthermore, the Australian Unique Device Identification Database (AusUDID) is the central database supporting Australia’s UDI system. It stores UDI records for medical devices supplied in Australia. Therefore, manufacturers and sponsors need to consider the consistency and accuracy of information across device labels, packaging, regulatory documentation and UDI records.

TGA resource: Accessing and using the AusUDID ↗

Consequently, this means manufacturers should consider consistency across:

Device labels and packaging
UDI records
ARTG information
Instructions for Use
Patient Information Leaflets, where applicable
Manufacturer product information
Regulatory and technical documentation

Above all, it’s important to note that UDI data should be treated as regulated product information requiring ongoing governance, rather than simply as a one-time database submission.

Understanding UDI identifiers

Next, manufacturers and sponsors should work together to ensure device data submitted to the AusUDID is complete, accurate and consistent with the device being supplied. For example, the TGA provides an Australian UDI Data Dictionary describing the information fields, permitted values and other metadata used within the AusUDID.

Similarly, this becomes particularly important where manufacturers maintain large device portfolios, multiple packaging levels, numerous models or variants, or devices supplied by more than one Australian sponsor.

What manufacturers should do now

Determine whether UDI requirements apply to each device

First, review the classification and device type and determine the applicable implementation timeframe, rather than assuming that the same requirements apply across an entire portfolio. In addition, the TGA provides specific guidance to help manufacturers and sponsors determine which devices are within scope.

TGA resource: Scope of UDI requirements ↗

Confirm your compliance date

Second, Australia is introducing mandatory UDI requirements progressively according to device classification. Therefore, manufacturers should identify the applicable compliance date for every affected product family and incorporate these dates into their regulatory planning.

TGA resource: Complying with UDI timeframes for medical devices ↗

Confirm your UDI strategy

Then, determine the appropriate identifiers for your devices and confirm that the UDI and UDI carrier meet applicable Australian requirements. Besides that, manufacturers supplying products internationally should also assess how their existing global UDI processes interact with Australian requirements.

Review labels and packaging

After that, assess whether UDI information is correctly applied at the required packaging levels and determine whether any specific requirements apply to the device.

Prepare and validate AusUDID data

Meanwhile, identify the required data elements and compare them with existing product master data, regulatory documentation and ARTG information.

Check consistency across regulatory documentation

In other words, UDI information should align with relevant labels, Instructions for Use, product descriptions, regulatory information and other controlled documentation.

Establish change-control processes

Additionally, manufacturers should understand which product changes may require changes to UDI information or the allocation of a new UDI-DI. Accordingly, UDI considerations should therefore be incorporated into existing quality and regulatory change-control processes.

Define responsibilities between manufacturer and Australian sponsor

Finally, where the manufacturer is located outside Australia, responsibilities for generating, providing, submitting, maintaining and updating UDI information should be clearly established between the manufacturer and sponsor.

For example, for detailed implementation guidance, manufacturers and sponsors should refer directly to the TGA’s guidance below.

Complying with the Unique Device Identification requirements for medical devices ↗

UDI should be integrated into the quality system

Overall, one of the most important practical considerations is that UDI compliance should not operate as a standalone regulatory project. Instead, UDI can affect:

Labelling controls
Product master data
Regulatory records
Change control
Post-market surveillance
Recalls and other market actions
Communication between manufacturers and Australian sponsors

Hence, manufacturers should therefore consider incorporating UDI responsibilities into their Quality Management System and regulatory lifecycle processes, including procedures for reviewing and maintaining AusUDID information after initial submission.

What happens if a manufacturer cannot comply?

However, where an affected device cannot meet applicable UDI requirements by its compliance date, a sponsor may need to consider the TGA’s Consent to Supply pathway for UDI-related non-compliance. Still, consent is assessed by the TGA and should not be treated as a substitute for establishing an appropriate UDI compliance strategy.

TGA resource: UDI Consent to Supply process ↗

In that case, manufacturers identifying potential compliance gaps should assess them early and determine whether corrective action can be completed before affected devices are supplied.

Preparing for the next phase

In summary, the introduction of Australia’s UDI framework represents more than the addition of another identifier to medical device packaging. Rather, it creates a structured connection between the physical device, its regulatory information and its presence on the Australian market.

Meanwhile, for manufacturers, particularly those supplying devices internationally, the opportunity is to integrate Australian UDI requirements into existing global identification and regulatory processes while identifying Australian-specific requirements early.

In conclusion, a structured UDI readiness assessment can help identify gaps across device identifiers, labels, packaging, product data, ARTG information, AusUDID records and internal quality-system processes before they become compliance issues.

How RQSolutions can help

In addition, RQSolutions supports medical device manufacturers and sponsors in understanding and implementing Australian regulatory requirements. Specifically, we can assist with:

Assessing UDI applicability and compliance timeframes
Reviewing device and packaging information
Evaluating AusUDID data readiness
Identifying gaps between existing documentation and Australian requirements
Reviewing manufacturer and sponsor responsibilities
Integrating UDI requirements into broader Australian market-access and regulatory strategie

Further information

Finally, for the latest regulatory information, visit the TGA Unique Device Identification (UDI) Hub.

TGA Unique Device Identification (UDI) Hub ↗

This article provides general regulatory information and is not intended to constitute legal or regulatory advice. Regulatory requirements should be assessed in relation to the particular device and circumstances.

A Guide To Appointing Your Australian Sponsor

What your Australian Sponsor is responsible for — and the questions to ask before appointing one.

For an overseas medical device manufacturer planning to enter the Australian market, appointing an Australian Sponsor is an important regulatory decision.

Under Australia’s medical device regulatory framework, an overseas manufacturer requires an Australian Sponsor to supply its medical devices in Australia. But the Sponsor’s role goes well beyond submitting an application to the Therapeutic Goods Administration (TGA) — the Australian Sponsor becomes the regulatory link between the manufacturer and the TGA, and assumes important ongoing responsibilities associated with the device in Australia.

Choosing the right Sponsor should therefore be considered part of your Australian market-entry strategy, not simply an administrative step.

TGA resource: Steps to supply for medical device manufacturers ↗

What is an Australian Sponsor?

The Australian Sponsor is the Australian-based legal entity responsible for the medical device in Australia. For an overseas manufacturer, the Sponsor generally submits the application for inclusion of the medical device in the Australian Register of Therapeutic Goods (ARTG) and acts as the primary point of contact between the manufacturer and the TGA. The TGA specifically states that overseas manufacturers require an Australian Sponsor.

Importantly, a Sponsor is not simply a regulatory representative whose involvement ends when the ARTG inclusion is obtained — the Sponsor has ongoing regulatory responsibilities for the device while it is supplied in Australia.

TGA resource: Importing and supplying medical devices ↗

What is your Australian Sponsor legally responsible for?

The Sponsor assumes significant responsibilities under Australia’s therapeutic goods legislation. These responsibilities continue after the device has been included in the ARTG.

ARTG applications and maintenance

The Sponsor is responsible for applying to the TGA for inclusion of the relevant kind of medical device in the ARTG, and must ensure that information associated with the ARTG entry remains accurate and current. An ARTG entry is specific to the relevant Sponsor, manufacturer and kind of medical device.

TGA resource: Importing and supplying medical devices ↗

Communication with the TGA

The Australian Sponsor acts as an important regulatory contact between the TGA and the manufacturer. The Sponsor must be able to obtain information from the manufacturer and provide requested information to the TGA within applicable timeframes. This may include:

Technical documentation
Clinical evidence
Instructions for Use
Evidence supporting conformity assessment
Information relating to complaints or adverse events
Post-market information
Other documentation requested by the TGA

This makes the working relationship between the Sponsor and manufacturer particularly important.

Post-market surveillance and vigilance

The Sponsor’s responsibilities do not stop once market access has been achieved. Sponsors have ongoing obligations relating to the safety, quality and performance of devices supplied in Australia. These can include:

Monitoring complaints and safety information
Reporting adverse events within required timeframes
Responding to TGA requests for information
Maintaining appropriate records
Complying with conditions of ARTG inclusion
Supporting investigations
Communicating safety information
Working with the manufacturer when corrective action is necessary
Undertaking recalls or other market actions where required

The Sponsor therefore needs systems capable of managing regulatory obligations throughout the entire Australian lifecycle of the device.

The Sponsor needs access to your regulatory documentation

An Australian Sponsor does not necessarily need to physically hold every element of the manufacturer’s technical documentation at all times. However, the Sponsor must be able to obtain required information from the manufacturer and provide it to the TGA when requested.

This means the manufacturer-Sponsor relationship needs effective processes for:

Document access

Who holds the technical documentation, and how quickly can it be provided?

TGA requests

Who reviews and prepares responses when the TGA requests information?

Regulatory changes

How will the manufacturer inform the Sponsor of changes to the device, intended purpose, certification, labelling or manufacturing arrangements?

Post-market issues

How will complaints, adverse events, safety signals and corrective actions be communicated?

Recalls

Who is responsible for each activity if an Australian recall or other market action becomes necessary?

These responsibilities should be clearly established before the Sponsor relationship begins.

Choosing the right Australian Sponsor

Selecting an Australian Sponsor is a critical step in your market entry strategy and should be based on more than cost or convenience. The Sponsor becomes your ongoing regulatory representative in Australia and plays a key role in maintaining your ARTG inclusion, managing TGA interactions and supporting post-market obligations.

When evaluating potential Sponsors, manufacturers should consider:

Demonstrated experience with TGA medical device regulation
Responsiveness and communication processes
Capability to manage ongoing ARTG and post-market obligations
Transparency in regulatory decision-making and reporting
Systems for handling complaints, adverse events and recalls
Ability to support regulatory changes and product lifecycle updates
Clarity of responsibilities between manufacturer and Sponsor
Long-term partnership approach rather than transactional support

A strong Sponsor relationship should provide regulatory confidence, not just market access.

How RQSolutions supports manufacturers

RQSolutions acts as an Australian regulatory partner for overseas medical device manufacturers, supporting both initial market entry and ongoing compliance. We work with manufacturers to:

ct as Australian Sponsor where required
Manage ARTG applications and maintenance
Coordinate TGA communications and requests
Support post-market surveillance and regulatory obligations
Ensure ongoing compliance across the product lifecycle
Provide clear, responsive regulatory support aligned with commercial goals

Our focus is on building long-term regulatory stability in the Australian market, not just achieving initial approval.